nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.0126	0.0658	CcSEcCtD
Temsirolimus—Ageusia—Ramipril—type 1 diabetes mellitus	0.00771	0.0404	CcSEcCtD
Temsirolimus—Glossitis—Ramipril—type 1 diabetes mellitus	0.00678	0.0355	CcSEcCtD
Temsirolimus—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00656	0.0344	CcSEcCtD
Temsirolimus—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00568	0.0298	CcSEcCtD
Temsirolimus—MTOR—retina—type 1 diabetes mellitus	0.00558	0.0823	CbGeAlD
Temsirolimus—FKBP1A—retina—type 1 diabetes mellitus	0.00502	0.074	CbGeAlD
Temsirolimus—CYP3A7-CYP3A51P—nephron tubule—type 1 diabetes mellitus	0.00498	0.0733	CbGeAlD
Temsirolimus—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00481	0.0252	CcSEcCtD
Temsirolimus—MTOR—cardiovascular system—type 1 diabetes mellitus	0.00472	0.0696	CbGeAlD
Temsirolimus—MTOR—kidney—type 1 diabetes mellitus	0.00462	0.0681	CbGeAlD
Temsirolimus—MTOR—pancreas—type 1 diabetes mellitus	0.00459	0.0677	CbGeAlD
Temsirolimus—FKBP1A—cardiovascular system—type 1 diabetes mellitus	0.00425	0.0626	CbGeAlD
Temsirolimus—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00425	0.0223	CcSEcCtD
Temsirolimus—FKBP1A—kidney—type 1 diabetes mellitus	0.00416	0.0613	CbGeAlD
Temsirolimus—FKBP1A—pancreas—type 1 diabetes mellitus	0.00413	0.0608	CbGeAlD
Temsirolimus—Gastritis—Ramipril—type 1 diabetes mellitus	0.00401	0.021	CcSEcCtD
Temsirolimus—MTOR—lymphoid tissue—type 1 diabetes mellitus	0.00397	0.0585	CbGeAlD
Temsirolimus—Influenza—Ramipril—type 1 diabetes mellitus	0.00392	0.0205	CcSEcCtD
Temsirolimus—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00392	0.0205	CcSEcCtD
Temsirolimus—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00377	0.0197	CcSEcCtD
Temsirolimus—Neutropenia—Ramipril—type 1 diabetes mellitus	0.00367	0.0192	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00364	0.0191	CcSEcCtD
Temsirolimus—FKBP1A—lymphoid tissue—type 1 diabetes mellitus	0.00357	0.0526	CbGeAlD
Temsirolimus—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00346	0.0182	CcSEcCtD
Temsirolimus—Renal failure—Ramipril—type 1 diabetes mellitus	0.00344	0.018	CcSEcCtD
Temsirolimus—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00341	0.0178	CcSEcCtD
Temsirolimus—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.0034	0.0178	CcSEcCtD
Temsirolimus—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.0034	0.0178	CcSEcCtD
Temsirolimus—Epistaxis—Ramipril—type 1 diabetes mellitus	0.0033	0.0173	CcSEcCtD
Temsirolimus—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00328	0.0172	CcSEcCtD
Temsirolimus—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00309	0.0162	CcSEcCtD
Temsirolimus—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00308	0.0162	CcSEcCtD
Temsirolimus—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00297	0.0155	CcSEcCtD
Temsirolimus—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00283	0.0148	CcSEcCtD
Temsirolimus—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00283	0.0148	CcSEcCtD
Temsirolimus—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00275	0.0144	CcSEcCtD
Temsirolimus—Erythema—Ramipril—type 1 diabetes mellitus	0.00273	0.0143	CcSEcCtD
Temsirolimus—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00273	0.0143	CcSEcCtD
Temsirolimus—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00267	0.014	CcSEcCtD
Temsirolimus—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.00256	0.0377	CbGeAlD
Temsirolimus—Angioedema—Ramipril—type 1 diabetes mellitus	0.0025	0.0131	CcSEcCtD
Temsirolimus—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00244	0.0128	CcSEcCtD
Temsirolimus—Cough—Ramipril—type 1 diabetes mellitus	0.00238	0.0125	CcSEcCtD
Temsirolimus—Convulsion—Ramipril—type 1 diabetes mellitus	0.00237	0.0124	CcSEcCtD
Temsirolimus—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00233	0.0122	CcSEcCtD
Temsirolimus—Myalgia—Ramipril—type 1 diabetes mellitus	0.00233	0.0122	CcSEcCtD
Temsirolimus—Chest pain—Ramipril—type 1 diabetes mellitus	0.00233	0.0122	CcSEcCtD
Temsirolimus—Anxiety—Ramipril—type 1 diabetes mellitus	0.00232	0.0121	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00231	0.0121	CcSEcCtD
Temsirolimus—Oedema—Ramipril—type 1 diabetes mellitus	0.00223	0.0117	CcSEcCtD
Temsirolimus—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00223	0.0117	CcSEcCtD
Temsirolimus—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00219	0.0115	CcSEcCtD
Temsirolimus—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00218	0.0114	CcSEcCtD
Temsirolimus—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00216	0.0113	CcSEcCtD
Temsirolimus—Anorexia—Ramipril—type 1 diabetes mellitus	0.00212	0.0111	CcSEcCtD
Temsirolimus—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.00206	0.0304	CbGeAlD
Temsirolimus—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00203	0.0106	CcSEcCtD
Temsirolimus—Insomnia—Ramipril—type 1 diabetes mellitus	0.00202	0.0106	CcSEcCtD
Temsirolimus—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00199	0.0104	CcSEcCtD
Temsirolimus—Somnolence—Ramipril—type 1 diabetes mellitus	0.00198	0.0104	CcSEcCtD
Temsirolimus—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00194	0.0102	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00192	0.0101	CcSEcCtD
Temsirolimus—Fatigue—Ramipril—type 1 diabetes mellitus	0.00192	0.0101	CcSEcCtD
Temsirolimus—Constipation—Ramipril—type 1 diabetes mellitus	0.00191	0.00999	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00182	0.00955	CcSEcCtD
Temsirolimus—CYP3A5—kidney—type 1 diabetes mellitus	0.00181	0.0267	CbGeAlD
Temsirolimus—CYP3A5—pancreas—type 1 diabetes mellitus	0.0018	0.0265	CbGeAlD
Temsirolimus—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00176	0.00923	CcSEcCtD
Temsirolimus—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00176	0.00923	CcSEcCtD
Temsirolimus—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00164	0.0086	CcSEcCtD
Temsirolimus—Asthenia—Ramipril—type 1 diabetes mellitus	0.0016	0.00838	CcSEcCtD
Temsirolimus—Pruritus—Ramipril—type 1 diabetes mellitus	0.00158	0.00826	CcSEcCtD
Temsirolimus—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00153	0.00799	CcSEcCtD
Temsirolimus—Dizziness—Ramipril—type 1 diabetes mellitus	0.00147	0.00772	CcSEcCtD
Temsirolimus—Vomiting—Ramipril—type 1 diabetes mellitus	0.00142	0.00743	CcSEcCtD
Temsirolimus—Rash—Ramipril—type 1 diabetes mellitus	0.00141	0.00736	CcSEcCtD
Temsirolimus—Dermatitis—Ramipril—type 1 diabetes mellitus	0.0014	0.00736	CcSEcCtD
Temsirolimus—Headache—Ramipril—type 1 diabetes mellitus	0.0014	0.00732	CcSEcCtD
Temsirolimus—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00136	0.02	CbGeAlD
Temsirolimus—CYP3A4—kidney—type 1 diabetes mellitus	0.00136	0.02	CbGeAlD
Temsirolimus—CYP2D6—kidney—type 1 diabetes mellitus	0.00134	0.0197	CbGeAlD
Temsirolimus—Nausea—Ramipril—type 1 diabetes mellitus	0.00132	0.00694	CcSEcCtD
Temsirolimus—ABCB1—retina—type 1 diabetes mellitus	0.00116	0.0171	CbGeAlD
Temsirolimus—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00109	0.0161	CbGeAlD
Temsirolimus—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000983	0.0145	CbGeAlD
Temsirolimus—ABCB1—kidney—type 1 diabetes mellitus	0.000962	0.0142	CbGeAlD
Temsirolimus—ABCB1—pancreas—type 1 diabetes mellitus	0.000955	0.0141	CbGeAlD
Temsirolimus—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000826	0.0122	CbGeAlD
Temsirolimus—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.0004	0.000539	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—EGFR—type 1 diabetes mellitus	0.000398	0.000537	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DQA1—type 1 diabetes mellitus	0.000396	0.000534	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—type 1 diabetes mellitus	0.000393	0.00053	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000392	0.000529	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00039	0.000526	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00039	0.000526	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000386	0.000521	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—G6PC2—type 1 diabetes mellitus	0.000383	0.000516	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—LGALS3—type 1 diabetes mellitus	0.00038	0.000512	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—EGFR—type 1 diabetes mellitus	0.000375	0.000506	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—EGFR—type 1 diabetes mellitus	0.000375	0.000506	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—type 1 diabetes mellitus	0.000375	0.000506	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD86—type 1 diabetes mellitus	0.000372	0.000501	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—EGFR—type 1 diabetes mellitus	0.000371	0.000501	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DQB1—type 1 diabetes mellitus	0.00037	0.0005	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—EGFR—type 1 diabetes mellitus	0.000368	0.000497	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000368	0.000496	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—EGFR—type 1 diabetes mellitus	0.000366	0.000494	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—STAT3—type 1 diabetes mellitus	0.000365	0.000493	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ITPR3—type 1 diabetes mellitus	0.000363	0.000489	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFIH1—type 1 diabetes mellitus	0.00036	0.000486	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD86—type 1 diabetes mellitus	0.000357	0.000481	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD86—type 1 diabetes mellitus	0.000355	0.000479	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000353	0.000476	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SLC11A1—type 1 diabetes mellitus	0.000351	0.000473	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD40LG—type 1 diabetes mellitus	0.00035	0.000472	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—EGFR—type 1 diabetes mellitus	0.000347	0.000468	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HLA-B—type 1 diabetes mellitus	0.000347	0.000467	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD8A—type 1 diabetes mellitus	0.000346	0.000467	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—type 1 diabetes mellitus	0.000345	0.000466	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000342	0.000462	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000341	0.00046	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—ERBB3—type 1 diabetes mellitus	0.000335	0.000452	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ITPR3—type 1 diabetes mellitus	0.000335	0.000452	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CASP3—type 1 diabetes mellitus	0.000334	0.000451	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-B—type 1 diabetes mellitus	0.000333	0.000449	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—type 1 diabetes mellitus	0.000332	0.000448	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ABCC8—type 1 diabetes mellitus	0.000332	0.000447	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—type 1 diabetes mellitus	0.000331	0.000446	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTPN2—type 1 diabetes mellitus	0.000329	0.000444	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—B2M—type 1 diabetes mellitus	0.000326	0.000439	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—type 1 diabetes mellitus	0.000325	0.000439	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—ERBB3—type 1 diabetes mellitus	0.000322	0.000434	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—ERBB3—type 1 diabetes mellitus	0.00032	0.000432	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CCR5—type 1 diabetes mellitus	0.000315	0.000425	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOC3—type 1 diabetes mellitus	0.000313	0.000422	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IAPP—type 1 diabetes mellitus	0.000313	0.000422	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—type 1 diabetes mellitus	0.000311	0.000419	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—type 1 diabetes mellitus	0.000309	0.000417	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-A—type 1 diabetes mellitus	0.000308	0.000416	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—type 1 diabetes mellitus	0.000308	0.000415	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HLA-A—type 1 diabetes mellitus	0.000307	0.000414	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CRP—type 1 diabetes mellitus	0.000306	0.000413	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—type 1 diabetes mellitus	0.000306	0.000413	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000305	0.000412	CbGpPWpGaD
Temsirolimus—MTOR—Disease—B2M—type 1 diabetes mellitus	0.000301	0.000406	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.0003	0.000404	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—STAT3—type 1 diabetes mellitus	0.000299	0.000404	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000296	0.000399	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HBA2—type 1 diabetes mellitus	0.000294	0.000397	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000294	0.000396	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.000293	0.000395	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—type 1 diabetes mellitus	0.000288	0.000389	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	0.000288	0.000389	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—type 1 diabetes mellitus	0.000288	0.000389	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DPB1—type 1 diabetes mellitus	0.000288	0.000388	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—type 1 diabetes mellitus	0.000285	0.000385	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000285	0.000385	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000284	0.000384	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-E—type 1 diabetes mellitus	0.000283	0.000382	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	0.000283	0.000382	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000282	0.00038	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—type 1 diabetes mellitus	0.000282	0.00038	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000281	0.000379	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000281	0.000379	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000278	0.000375	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000278	0.000375	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—G6PC2—type 1 diabetes mellitus	0.000277	0.000373	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTLA4—type 1 diabetes mellitus	0.000273	0.000368	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000272	0.000367	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD80—type 1 diabetes mellitus	0.000271	0.000366	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.00027	0.000364	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS2—type 1 diabetes mellitus	0.000267	0.00036	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000262	0.000354	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000261	0.000352	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD79A—type 1 diabetes mellitus	0.00026	0.000351	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD80—type 1 diabetes mellitus	0.00026	0.000351	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD80—type 1 diabetes mellitus	0.000259	0.00035	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000258	0.000348	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000258	0.000348	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PRKCQ—type 1 diabetes mellitus	0.000256	0.000345	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000255	0.000344	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	0.000255	0.000344	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS1—type 1 diabetes mellitus	0.000252	0.00034	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000249	0.000336	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—VAV1—type 1 diabetes mellitus	0.000248	0.000335	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—INS—type 1 diabetes mellitus	0.000245	0.00033	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DQA1—type 1 diabetes mellitus	0.00024	0.000324	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	0.00024	0.000323	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000236	0.000318	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PRKCQ—type 1 diabetes mellitus	0.000236	0.000318	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000234	0.000316	CbGpPWpGaD
Temsirolimus—MTOR—Disease—VAV1—type 1 diabetes mellitus	0.000229	0.000309	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TYK2—type 1 diabetes mellitus	0.000229	0.000309	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DQB1—type 1 diabetes mellitus	0.000225	0.000303	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000224	0.000303	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000222	0.000299	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ITPR3—type 1 diabetes mellitus	0.000221	0.000299	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000221	0.000298	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000221	0.000298	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000219	0.000296	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000219	0.000296	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TYK2—type 1 diabetes mellitus	0.000219	0.000295	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000217	0.000293	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD86—type 1 diabetes mellitus	0.000216	0.000292	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS3—type 1 diabetes mellitus	0.000215	0.00029	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40LG—type 1 diabetes mellitus	0.000212	0.000286	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD8A—type 1 diabetes mellitus	0.00021	0.000283	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—type 1 diabetes mellitus	0.000209	0.000282	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000209	0.000282	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000209	0.000282	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—HBA1—type 1 diabetes mellitus	0.000208	0.000281	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—APOC3—type 1 diabetes mellitus	0.000207	0.000279	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—type 1 diabetes mellitus	0.000207	0.000279	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTT1—type 1 diabetes mellitus	0.000203	0.000274	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-B—type 1 diabetes mellitus	0.000202	0.000272	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD86—type 1 diabetes mellitus	0.0002	0.00027	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000199	0.000268	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—type 1 diabetes mellitus	0.000199	0.000268	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—type 1 diabetes mellitus	0.000198	0.000267	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000197	0.000265	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000196	0.000265	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ERBB3—type 1 diabetes mellitus	0.000195	0.000263	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SST—type 1 diabetes mellitus	0.000193	0.00026	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000192	0.000259	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00019	0.000256	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2RA—type 1 diabetes mellitus	0.000189	0.000255	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-A—type 1 diabetes mellitus	0.000187	0.000252	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000181	0.000245	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000181	0.000244	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ERBB3—type 1 diabetes mellitus	0.00018	0.000243	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CRP—type 1 diabetes mellitus	0.000178	0.000241	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CCR5—type 1 diabetes mellitus	0.000177	0.000239	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HLA-A—type 1 diabetes mellitus	0.000173	0.000233	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000172	0.000232	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000171	0.000231	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DRB1—type 1 diabetes mellitus	0.000171	0.00023	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.00017	0.00023	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000166	0.000224	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000165	0.000223	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GCG—type 1 diabetes mellitus	0.000162	0.000219	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00016	0.000216	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.00016	0.000216	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	0.00016	0.000216	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD80—type 1 diabetes mellitus	0.000158	0.000213	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000153	0.000207	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STAT3—type 1 diabetes mellitus	0.000153	0.000207	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000152	0.000205	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	0.000151	0.000203	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.00015	0.000203	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS2—type 1 diabetes mellitus	0.00015	0.000203	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	0.00015	0.000202	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	0.000147	0.000198	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD80—type 1 diabetes mellitus	0.000146	0.000197	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EGFR—type 1 diabetes mellitus	0.000146	0.000196	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000145	0.000196	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000145	0.000195	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000143	0.000193	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CD86—type 1 diabetes mellitus	0.00014	0.000189	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—EGFR—type 1 diabetes mellitus	0.00014	0.000189	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EGFR—type 1 diabetes mellitus	0.000139	0.000188	CbGpPWpGaD
Temsirolimus—MTOR—Disease—INS—type 1 diabetes mellitus	0.000138	0.000186	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CAT—type 1 diabetes mellitus	0.000137	0.000185	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000137	0.000184	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000135	0.000182	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TYK2—type 1 diabetes mellitus	0.000133	0.00018	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000133	0.000179	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.000129	0.000173	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000128	0.000172	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000127	0.000172	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000126	0.00017	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—type 1 diabetes mellitus	0.000125	0.000168	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000124	0.000167	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TYK2—type 1 diabetes mellitus	0.000123	0.000166	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000122	0.000165	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS3—type 1 diabetes mellitus	0.000121	0.000163	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000121	0.000163	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—type 1 diabetes mellitus	0.000121	0.000163	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	0.000117	0.000158	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	0.000114	0.000153	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	0.000114	0.000153	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	0.000113	0.000152	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—type 1 diabetes mellitus	0.000112	0.000151	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000111	0.00015	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—type 1 diabetes mellitus	0.000111	0.00015	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—type 1 diabetes mellitus	0.000111	0.00015	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000111	0.00015	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—type 1 diabetes mellitus	0.000111	0.00015	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000107	0.000145	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	0.000107	0.000144	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—type 1 diabetes mellitus	0.000107	0.000144	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	0.000106	0.000144	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	0.000104	0.000141	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000102	0.000138	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	9.91e-05	0.000134	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.75e-05	0.000132	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	9.72e-05	0.000131	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—INS—type 1 diabetes mellitus	9.64e-05	0.00013	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STAT3—type 1 diabetes mellitus	9.33e-05	0.000126	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.33e-05	0.000126	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—INS—type 1 diabetes mellitus	9.1e-05	0.000123	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	8.84e-05	0.000119	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	8.81e-05	0.000119	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.62e-05	0.000116	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STAT3—type 1 diabetes mellitus	8.61e-05	0.000116	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGFR—type 1 diabetes mellitus	8.48e-05	0.000114	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.46e-05	0.000114	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—type 1 diabetes mellitus	8.34e-05	0.000113	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	8.33e-05	0.000112	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	7.98e-05	0.000108	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGFR—type 1 diabetes mellitus	7.83e-05	0.000106	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—type 1 diabetes mellitus	7.49e-05	0.000101	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	7.48e-05	0.000101	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	7.44e-05	0.0001	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.18e-05	9.69e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—type 1 diabetes mellitus	7.17e-05	9.67e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	7.05e-05	9.51e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	7e-05	9.44e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	6.96e-05	9.38e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	6.83e-05	9.22e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	6.58e-05	8.88e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—type 1 diabetes mellitus	6.52e-05	8.79e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.03e-05	8.14e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	6.03e-05	8.14e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—type 1 diabetes mellitus	6.02e-05	8.12e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	5.77e-05	7.78e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.48e-05	7.4e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	5.44e-05	7.34e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—INS—type 1 diabetes mellitus	4.96e-05	6.7e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	4.68e-05	6.31e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	4.61e-05	6.22e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	4.55e-05	6.14e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	4.35e-05	5.87e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	4.29e-05	5.79e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—type 1 diabetes mellitus	4.21e-05	5.68e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	4.1e-05	5.53e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	3.06e-05	4.13e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.8e-05	3.78e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.68e-05	3.62e-05	CbGpPWpGaD
